Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Oxford Nanopore Sues PacBio in Europe Alleging Infringement of Harvard IP

This article, originally published on April 21, has been updated with additional information from Oxford Nanopore Technologies.

NEW YORK (GenomeWeb) – Oxford Nanopore Technologies said today that it has initiated legal proceedings in Europe against Pacific Biosciences, alleging infringement of intellectual property from Harvard University for which Oxford holds an exclusive license.

The company filed one lawsuit in the Patents Court of the High Court's Chancery Division in the UK and another with a court in Mannheim, Germany.

The patent, EP 1192453, is entitled "Molecular and atomic scale evaluation of biopolymers" and lists Daniel Branton, Timothy Denison, and Jene Golovchenko as inventors.

Oxford Nanopore declined to comment further on the action at this time. PacBio also declined to comment.

PacBio filed a lawsuit against Oxford Nanopore in March, alleging that the firm infringes on a patent PacBio holds related to single-molecule sequencing.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.